|
James A. McCarthy, CLP™, Senior Vice President, Corporate Development |
|
Joined Expression Genetics in March 2008. Jim McCarthy has thirty years of life sciences professional experiences. His background includes a twenty five year career with Bristol-Myers Squibb and Eli Lilly & Company in a variety of expanding roles and responsibilities. He has spent over fifteen years in corporate business development and licensing roles with pharmaceutical, medical device and ethical nutrition businesses. These efforts included projects in over 30 countries and resulted in over 50 completed agreements across a range of external growth alliance transactions (i.e. acquisitions, licensing, research agreements etc.). - His experience includes pharmaceutical marketing positions involving the start up of strategic therapeutic business units, new product introductions and life cycle management of established products in oncology, central nervous system and cardiovascular fields, and in the cardiac device market. His background includes serving as Vice-President, Corporate Development, North America for PharmaVentures, Ltd.; Vice-President, Corporate Development, for Technology Innovations, LLC, and with the Arthur Young Health Care Consulting Group. He is a recipient of the Certified Licensing Professional (CLP™) designation and has been a long term member of the Licensing Executive Society (LES) where he served as Chairperson for the 2007 “LES BioPharmaceutical Royalty Rate and Deal Terms Survey”, the Association of Corporate Growth (ACG), and the Association of University Technology Managers (AUTM). Jim has conducted professional presentations on international business development, licensing and technology commercialization both in the U.S. and abroad.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|